Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity
Description
CONCLUSIONS: These results demonstrate that SARS-CoV-2 infection can increase autoantibody levels to ACE2 and other immune factors. The levels of these autoantibodies are associated with COVID-19 disease severity.
